Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 3.1 Amended and Restated Certificate of Incorporation of Celularity Inc.
- 3.2 Amended and Restated Bylaws of Celularity Inc.
- 4.1 Specimen Common Stock Certificate of the Company
- 4.2 Specimen Warrant Certificate of the Company
- 10.3 Amended and Restated Registration Rights Agreement
- 10.4 Vesting Agreement Dated As of July 16, 2021 by and Among GX Sponsor LLC, Celularity Inc. (F/k/a GX Acquisition Corp.), and Each of the Other Persons Set Forth on the Signature Pages Thereto
- 10.15 Form of Deferred Compensation Grant Notice
- 16.1 Letter from Marcum LLP
- 21.1 List of Subsidiaries
- 99.1 Press Release Dated July 16, 2021
- 99.2 Unaudited Pro Forma Condensed Combined Financial Information As of and for the Year Ended December 31, 2020 and As of and for the Three Months Ended March 31, 2021
CELU similar filings
- 20 Aug 21 Financial Statements and Exhibits
- 16 Aug 21 Completion of Acquisition or Disposition of Assets
- 16 Aug 21 Celularity Reports Second Quarter 2021 Financial Results
- 22 Jul 21 Celularity Closes Merger with GX Acquisition Corp and Provides Corporate Update
- 15 Jul 21 Submission of Matters to a Vote of Security Holders
- 1 Jul 21 Celularity and Arthrex Enter into Exclusive Supply and Distribution Agreement for Multiple Commercial Products
- 29 Jun 21 Regulation FD Disclosure
Filing view
External links